timothy sykes logo
MRM Stock Slides As Traders Track Support Levels Thumbnail
G Google News

MRM Stock Slides As Traders Track Support Levels

JACK KELLOGG•UPDATED MAY. 22, 2026, 9:18 AM ET
Reviewed by Tim Sykesand Fact-checked by Ellis Hobbs

MEDIROM Healthcare Technologies Inc. stocks have been trading up by 20.0 percent following upbeat news fueling strong investor optimism.

Candlestick Chart

Live Update At 09:18:10 EDT: On Friday, May 22, 2026 MEDIROM Healthcare Technologies Inc. stock [NASDAQ: MRM] is trending up by 20.0%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

MRM is trading like a tiny, beaten-down value play with real balance-sheet risk. Over the last several sessions, MEDIROM Healthcare Technologies Inc. has slid from closes near $1.22–$1.21 down toward $0.92–$0.98. That’s a meaningful percentage drop in a short time, and traders should treat it as a clear sign of selling pressure.

On the fundamentals side, MRM posted roughly ¥8,299,134,000 in revenue, while the current market is valuing the company at only about 0.14 times sales and 1.23 times book value. A P/E near 5 says traders are not paying up for those earnings. Cheap doesn’t mean safe.

The balance sheet for MEDIROM Healthcare Technologies Inc. shows about ¥329,399,000 in cash against current liabilities of more than ¥4,181,481,000 and negative working capital around ¥1,475,419,000. That tells traders MRM has to juggle short-term obligations carefully. Leverage is high, with total liabilities at roughly ¥6,902,613,000 on assets near ¥8,090,671,000. For active traders, that mix of low valuation and tight liquidity creates both opportunity and real risk.

Why Traders Are Watching MRM Price Action

MRM is a classic low-priced, thin name that can move fast when day traders show up. Look at the intraday tape. MEDIROM Healthcare Technologies Inc. spiked early from around $1.43 up to $2 at 04:00, then immediately sold off, closing that candle near $1.56. That kind of wick screams failed breakout and aggressive profit-taking.

From there, every bounce in MRM has been sold. The stock pushed as high as $1.68 at 04:15 and then faded into the mid‑$1.30s, then the $1.40s, and later settled into a choppy downtrend. By the time MRM moved into the regular session-style hours on this chart, those highs were gone. MEDIROM Healthcare Technologies Inc. traded a series of lower highs between $1.28 and $1.22, with closes slowly walking down from $1.28 to $1.17.

On the daily chart, MRM has been leaking from the $1.20s to just under $1.00, with recent closes around $0.92–$0.98. That $0.90 zone has acted as a floor several times. Traders in this community know what that means: if MEDIROM Healthcare Technologies Inc. cracks that area on volume, you can see a fast flush. If it holds and bounces, MRM might offer a clean, oversold spike.

The fundamentals add fuel to that narrative. A cheap P/E and low price-to-sales tell the story of a stock the market has written off, while heavy short-term debt keeps pressure on MEDIROM Healthcare Technologies Inc. Any hint of stronger cash generation or debt progress can re-rate MRM quickly, which is why short-term traders keep it on watch.

More Breaking News

Conclusion

MRM sits at an interesting crossroad. The chart shows a clear downtrend from the $1.20s into the $0.90s, with intraday action marked by failed spikes and fading rallies. At the same time, MEDIROM Healthcare Technologies Inc. sports solid reported revenue relative to its tiny market value and a P/E near 5, signaling that traders have priced in a lot of fear. The balance sheet, with negative working capital and sizable current debt, explains that discount.

For active traders, that mix of pressure and potential is exactly what builds explosive moves. If MRM loses the $0.90–$0.95 area with volume, MEDIROM Healthcare Technologies Inc. can quickly become a textbook short-side momentum play. If instead MRM holds that support and starts putting in higher lows, a sharp bounce toward the $1.10–$1.20 region is on the table.

The key is to treat MEDIROM Healthcare Technologies Inc. like a trade, not a story. As Tim Sykes likes to tell students, “Patterns repeat, but you have to be prepared and disciplined to take advantage of them.” As millionaire penny stock trader and teacher Tim Sykes, says, “It’s better to go home at zero than to go home in the red.”. Traders studying MRM should map their levels, size small, and cut losses fast. This analysis is for educational and research purposes only, and every trader must make their own decisions based on their own rules.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading MRM

Millionaire's
POV on MRM

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”